The Melbourne drug development company has announced Dr Tim Oldham as its new CEO and signed a commercial agreement for its i-body platform with GE Healthcare.
The 2019 Nobel Prizes acknowledge scientists whose discoveries have opened up possibilities for humankind that were previously unfathomable.
Thirteen Australian institutions have received Athena SWAN Institutional Bronze Awards as part of the Science in Australia Gender Equity (SAGE) initiative.
The investment will see the Australian Space Agency foster the new ideas and high-tech skilled jobs that should make Australian businesses a partner of choice to fit out NASA missions.
Scientists from the University of Tasmania are among an international research team that recently set out to crack the secret of the unique cubed poo of wombats.
Thermo Fisher Scientific has entered into a collaboration with Cedars-Sinai and elected Debora Spar to its board of directors.
Australia's own Jacques Miller is among the winners of the 2019 Lasker Awards, widely regarded as America's top biomedical research prize.
Described as Australia's leading science awards, the prizes saw trophies and $170,000 in prize money presented across four categories.
The 2nd ChemLinked Food Regulatory Conference – Oceania 2019 (CLFRC 2019) is being held on 20 November 2019 at the PARKROYAL Darling Harbour, Sydney.
The Fellowship provides support to projects that have a local community focus and which often struggle to secure funding or face high competition.
The Australian Government will provide over $30 million to 16 projects under Round 7 of the Cooperative Research Centres Projects (CRC-P) grants.
Integrated DNA Technologies has announced two new partnerships as part of its mission to break down the barriers in genomics research.
The 57th AACB Annual Scientific Conference will be held at Adelaide Convention Centre from 15–17 October under the theme 'Clinical Biochemistry: Optimising Value in Healthcare'.
Abcam has announced its acquisition of the entire live cell line and lysates portfolio of EdiGene, a Chinese company focused on developing genome editing technologies into novel therapeutics.